Pathogen and antimicrobial resistance testing

Patent metadata

Field	Value
Publication number	US-12054791-B2
Application number	US-202117171951-A
Country	US
Kind code	B2
Filing date	Feb 9, 2021
Priority date	Sep 4, 2014
Publication date	Aug 6, 2024
Grant date	Aug 6, 2024

Abstract

Systems and methods for determining pathogens and antimicrobial resistance of pathogens in a sample are provided.

First claim

The invention claimed is:

1. A method for analysis of a sample, the method comprising:
receiving a cartridge in a sample processing device, wherein the sample processing device comprises a fluid handling system, and wherein the cartridge comprises:
a sample,
an antimicrobial,
a microorganism growth medium, and
a reagent for a nucleic acid amplification reaction;

transferring, by the fluid handling system, a first portion of the sample from a first region of the cartridge to a second region of the cartridge in fluid communication with the reagent for the nucleic acid amplification reaction, to generate a first mixture comprising the first portion of the sample and the reagent for the nucleic acid amplification reaction;
transferring, by the fluid handling system, a second portion of the sample from the first region of the cartridge to a third region of the cartridge fluid communication with the antimicrobial and the microorganism growth medium, to generate a second mixture comprising the second portion of the sample, the antimicrobial, and the microorganism growth medium;
incubating the first mixture under conditions sufficient to support the amplification of a nucleic acid of the pathogen in the sample;
culturing the second mixture under conditions sufficient to support growth of the pathogen in the second mixture;
detecting amplification of the nucleic acid from the pathogen in the sample; and
detecting growth of the pathogen in the sample.

2. The method of claim 1 , wherein detecting amplification of the nucleic acid from the pathogen in the sample comprises detecting fluorescence from a dye in the first mixture.

3. The method of claim 1 , wherein the detecting amplification of the nucleic acid from the pathogen in the sample and the detecting of the growth of the pathogen in the sample both occur no more than 24 hours after the cartridge is received in the sample processing device.

4. A method for analysis of a sample, the method comprising:
receiving a cartridge in a sample processing device, wherein the sample processing device comprises a fluid handling system, and wherein the cartridge comprises:
a sample,
an antimicrobial,
a microorganism growth medium; and
a nucleic acid probe capable of specifically hybridizing to a nucleic acid, or a complement thereof, of the pathogen;

transferring, by the fluid handling system, a first portion of the sample from a first region of the cartridge to a second region of the cartridge in fluid communication with the nucleic acid probe, to generate a first mixture comprising the first portion of the sample and the nucleic acid probe;
transferring, by the fluid handling system, a second portion of the sample from the first region of the cartridge to a third region of the cartridge in fluid communication with the antimicrobial and the microorganism growth medium, to generate a second mixture comprising the second portion of the sample, the antimicrobial, and the microorganism growth medium;
incubating the first mixture under conditions sufficient to specifically hybridize to a nucleic acid, or a complement thereof, of the pathogen in the sample;
culturing the second mixture under conditions sufficient to support growth of the pathogen;
detecting the nucleic acid of the pathogen in the sample; and
detecting growth of the pathogen in the sample.

5. The method of claim 4 , wherein detecting growth of the pathogen in the sample comprises examining the second mixture with a cytometer.

6. The method of claim 5 , wherein examining comprises counting the number of pathogen cells.

7. The method of claim 5 , wherein examining comprises detecting an antigen of the pathogen.

8. The method of claim 5 , wherein examining comprises determining a ratio or number of pathogen cells undergoing cell division.

9. The method of claim 4 , wherein detecting growth of the pathogen in the sample comprises examining the second mixture with a spectrophotometer.

10. The method of claim 9 , wherein examining comprises determining the optical density of the second mixture.

11. The method of claim 10 , wherein the method comprises:
transferring, by the fluid handling system, the second portion of the sample into fluid communication with the antimicrobial, the microorganism growth medium, and a metabolic indicator, configured to be metabolized to produce a metabolic product, to generate a second mixture comprising the second portion of the sample, the antimicrobial, the microorganism growth medium, and the metabolic indicator.

12. The method of claim 11 , wherein the metabolic indicator is selected from resazurin, 5-cyano-2,3-ditolyl tetrazolium chloride (CTC), carboxyfluorescein diacetate succinimidyl ester (CFDA-SE), and luciferin.

13. The method of claim 12 , wherein the metabolic indicator is resazurin.

Assignees

• Labrador Diagnostics Llc

Inventors

• Holmes Elizabeth A
• Shee Chandan
• Lui Clarissa

Classifications

• G01N2469/10

  Detection of antigens from microorganism in sample from host · CPC title

• G01N33/56911

  Bacteria · CPC title

• C12Q2600/156

  Polymorphic or mutational markers · CPC title

• G01N2469/20

  Detection of antibodies in sample from host which are directed against antigens from microorganisms · CPC title

• G01N33/53

  Immunoassay; Biospecific binding assay; Materials therefor · CPC title